• 22. Dezember 2024

New LEADER Analysis Shows Victoza® Reduces Cardiovascular Risk in People With Type 2 Diabetes Regardless of Severe Hypoglycaemia Events

ByNovo Nordisk A/S

Jun 13, 2017